High-concentration monoclonal antibodies (mAbs) are gaining prominence given the compliance and cost advantages.

In advance of CPHI 2024 next month, we have compiled our pick of the sessions for BioTechniques members, alongside everything you need to know for the conference. Where? When? Who? This year’s meeting ...

At this October’s CPHI event being held in Milan, dsm-firmenich, is inviting stakeholders across the pharmaceutical market to ...

discussed new advancements in ADC technologies, including the role of complex chemistries. Pharmaceutical Technology® Europe spoke with Nicolas Camper, senior director—Bioconjugation Chemistry at ...

At CPHI Milan 2024, Ardena will showcase its latest advancements in drug development and manufacturing, including the launch ...

Neopac, a company based in Switzerland that provides packaging and dosing solutions for pharmaceutical, oral, and beauty care, will unveil at CPHI Milan its new mono-material barrier (MMB) mini tubes, ...

At CPHI Europe, Angela Vollstedt, global director of Cell & Gene Therapies at Novartis discussed scale up strategies for cell ...

Celebrating this pivotal milestone, IFF will spotlight its latest solutions for nitrosamine mitigation at CPHI 2024, Milan, Oct. 8-10, booth 6B10. The range includes a new portfolio of low nitrite ...